Earnings Releases·Nov 5, 2026, 7:09 AM ET

Certara — Third Quarter 2026 Earnings Summary

Total revenue increased 4% year-over-year to $94.9 million, driven by 11% growth in software revenue ($48.8 million) which offset a 2% decline in services revenue ($46.1 million).
Net loss from continuing operations narrowed 26% to $3.6 million, while adjusted EBITDA rose 6% to $30.2 million with a margin of 31.8%.
Full-year 2026 revenue growth guidance was narrowed to 2%–3%, with adjusted diluted EPS guidance updated to $0.31–$0.34.
The Regulatory and Medical Writing business was divested as of May 8, 2026, and Grant Peterson was appointed Chief Product Officer to accelerate product growth.
Capital return activity included $57.4 million in common stock repurchases during the first nine months, while cash and cash equivalents ended the quarter at $214.9 million.